Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)

Market Cap	2.33B -0.7%
Revenue (ttm)	659.66M +5.2%
Net Income	33.28M -22.5%
EPS	0.10 -22.5%
Shares Out	330.95M
PE Ratio	69.90
Forward PE	n/a
Dividend	0.08 (1.10%)
Ex-Dividend Date	May 29, 2026

Volume	6,239,100
Open	7.09
Previous Close	7.27
Day's Range	7.01 - 7.34
52-Week Range	6.94 - 9.68
Beta	0.18
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About SHE:002566

Jilin Jian Yisheng Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, wholesale, retail, import, and export of pharmaceutical products in China. The company offers paper packaging products; drugs comprising capsules, injections, tablets, granules, and other drug products; cosmetics; ginseng products; bee products; and food products comprising acai collagen solid drinks, multivitamin mineral tablets, collagen peptide juice drinks, and fruit lemon powder. It is also involved in pharmaceutic...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1997
• Employees: 1,656
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002566

Financial Performance

In 2025, SHE:002566's revenue was 640.17 million, a decrease of -4.23% compared to the previous year's 668.47 million. Earnings were 29.00 million, a decrease of -44.32%.